News
Custom melanoma vaccines provoke T cells
April 6, 2015 /
MATR Sponsor (view all)
Personalized melanoma vaccines can spark a powerful immune response against unique mutations in patients’ tumors, according to early data from a first-in-humans clinical trial.
The tailor-made vaccines, given to three patients with advanced melanoma, appeared to increase the number and diversity of cancer-fighting T cells responding to the tumors. The finding is a boost to cancer immunotherapy, a treatment strategy that unleashes the immune system to seek out and destroy cancer.
MATR Supporters (view all)
Posted in: Incubators and R&D
Sorry, we couldn't find any posts. Please try a different search.